Image: a sculpture of a woman's torso
Physicians share their experiences with the growing range of noninvasive fat reduction technologies.

In the five years since Zeltiq’s CoolSculpting device first received U.S. Food and Drug Administration (FDA) approval for the noninvasive destruction of fat in the abdomen, the medical aesthetics industry has seen an array of FDA-cleared fat reduction technologies enter the market. Each is designed to permanently thin down thighs, blast away back flab, whittle middles or slim chin chub with minimal or...

Articles

Image: a sculpture of a woman's torso

In the five years since Zeltiq’s CoolSculpting device first received U.S. Food and...

Image of David J. Waldron

Are you struggling with the challenges of employee management? Wondering how to track...

Image: Husband and wife team Drs. Chaffoo and Stuart

What happens when a couple in love goes into business together? For dermatologist...

Image: Man leaving through a door

When you graduated medical school, retirement was likely the last thing on your mind....

Products

Topix Phamaceuticals Replenix Pure Hydration Moisture Balm

Replenix Pure Hydration Moisture Balm from Topix Pharmaceuticals targets...

SkinBetter Science Smoothing Kit

All three products in the SkinBetter Science Smoothing Kit are formulated...

Rhonda Allison Pro Youth Skincare Duo

The Rhonda Allison Pro Youth Accelerated Duo combines two products...

Jane Iredale Makeup Kit

The Jane Iredale Pure & Simple Kit is a complete makeup regimen designed...

Blogs

Facebook Ad Leads
By Angela (Miller) Hamilton, Facebook Marketing Expert at ReachLocal With more than 1.71 billion active users on Facebook, social media advertising is an important way for medspas and medical practices to reach local consumers online. Most facilties have a company page and perhaps purchase a few...
Addressing Employee Tardiness
By Paul Edwards, CEO of CEDR HR Solutions There’s nothing more maddening than knowing your patients are due to arrive at your door at any moment, but because one or more of your employees STILL hasn’t shown up for work, you won’t be able to take the patients back right away. Despite the many...
Valeant Completes Debt-Reducing Refinancing Transactions

Valeant Pharmaceuticals International has closed its previously announced refinancing transactions. These include its offering of $1.25 billion aggregate principal amount of 6.50% senior secured notes due in 2022, and $2 billion aggregate principal amount of 7% senior secured notes due in 2024. The company borrowed an additional $3 billion (approximately) of new term loans maturing in 2022.

“Upon closing these transactions, the issuance of $1.25 billion and $2 billion of senior secured notes due 2022 and 2024, respectively, and the tender for $1.1 billion of our senior notes due 2018, the amount of our debt maturing prior to 2020 will be substantially reduced,” said Joseph C. Papa, chairman and CEO of Valeant. “In addition, the amended terms of the credit agreement will provide us with improved operating flexibility and a greater margin of safety with respect to financial covenants. Together, these transactions, coupled with our ongoing asset sale process, will enable Valeant to focus on driving the fundamental operating performance of its various businesses. We want to thank the lenders, investors and other financial institutions that supported us in the completion of this important initiative.”

Snipping Better Than Shaving Prior to Laser Hair Removal

Postmenopausal women with hirsutism are less likely to experience paradoxical hypertrichosis following treatment with an alexandrite laser if they snip their hair rather than shave it prior to treatment. Researchers Robabeh Alijanpour, MD, and Fatemeh Aliakbarpour, DDS, randomly divided 129 premenopausal women affected by hirsutism into two groups. Group A (66 patients) shaved their hair prior to laser treatment and Group B (63 patients) shortened their hair using scissors.

Each patient received six alexandrite laser therapy sessions every month for six consecutive months. Chin hairs in a 5 × 5 cm2 zone were counted, and the paradoxical hair regrowth was evaluated four times during the study: once at baseline, once before the third session, once before the sixth session, and once six months after the last laser session.

They found that alexandrite laser therapy was very effective in reducing hair counts in both groups. Prior to the third laser session, the hair counts were 15.06 ± 5.20 in Group A and 13.07 ± 4.44 in Group B. Before the sixth session hair counts were 2.80 ± 1.16 in Group A and 2.71 ± 1.12 in Group B. Six months after the last laser session, the counts were 11.27 ± 9.30 in Group A and 8...

Juvederm Vollure XC Approved in U.S.

Allergan’s Juvéderm Vollure XC, known as Volift outside of the U.S., has received FDA marketing clearance for the correction of moderate to severe facial wrinkles and folds, such as nasolabial folds, in adults over the age of 21.

The hyaluronic acid (HA)-based filler features Allergan’s Vycross technology, which blends different molecular weights of HA for longer-lasting results. In the U.S. pivotal clinical trial, a majority of subjects (59%) saw improvement in moderate to severe nasolabial folds that lasted up to 18 months. Patient satisfaction was high—82% of subjects said they were very satisfied at six months and 68% were satisfied with their results at 18 months.

“The FDA approval of Juvéderm Vollure XC demonstrates Allergan’s imperative to develop next-generation HA fillers designed to meet different patient needs,” said David Nicholson, chief research and development officer at Allergan.

AAD Commends FDA for Indoor Tanning Restrictions

The American Academy of Dermatology (AAD) applauds the U.S. Food and Drug Administration (FDA) for proposing new regulations governing indoor tanning, including an age restriction for minors under the age of 18 as well as a risk-acknowledgement form that all adults must sign before using indoor tanning devices.


According to the AAD, statistics show that millions of people tan indoors annually and the risk of developing melanoma increases by 59% for individuals exposed to UV radiation from indoor tanning—the risk increases with each use. If the FDA’s proposed rule becomes final,... more »

ASDS Honored With 14 MarCom Awards

The American Society for Dermatologic Surgery (ASDS) and American Society for Dermatologic Surgery Association (ASDSA) were recognized with 14 awards—including three Platinums—in the 2015 MarCom Awards.


The MarCom Awards competition is administered and judged by the Association of Marketing and Communication Professionals, selecting winners “whose work serves as a benchmark for the industry.” The 2015 competition received about 6,500 entries representing more than a dozen countries.


The Platinum Award—MarCom’s top honor—was presented to ASDS in three categories: Currents... more »

Cellfina Available in US

Merz Aesthetics has begun commercial shipment of the Cellfina System, indicated for long-term improvement in the appearance of cellulite in the buttocks and thighs, to aesthetic practices in the U.S.


Cellfina combines proprietary technology with minimally invasive subcision to treat the primary structural cause of dimpled cellulite. Results of the procedure last at least two years—in clinical trials, patient satisfaction with their treatment results improved from 94% at one year to 96% at the two-year mark. The most common side effects reported were soreness, tenderness and bruising... more »